Author Archive: Phyllis Arthur

Phyllis Arthur

Phyllis is Senior Director for Vaccines, Immunotherapeutics, and Diagnostics Policy at BIO.  In this role she is responsible for working with member companies in vaccines, molecular diagnostics, and bio-defense on policy, legislative, and regulatory issues.   Phyllis joined BIO in July 2009 as the Director of Healthcare Regulatory Affairs.

Prior to joining BIO, she worked in numerous marketing and sales positions for Merck & Co., Inc in their vaccine division.  Over her 16 year career, she has launched several exciting new vaccines in the United States and internationally, including the first HPV vaccine GARDASIL.  During her years in marketing she worked closely with clinical and academic thought leaders in infectious diseases, oncology, and public health.   In addition, she also led a large vaccine sales organization of over 75 representatives and managers, covering 14 states. Phyllis received her bachelor’s degree in economics and international politics from Goucher College and her M.B.A. from the Wharton School of Business at the University of Pennsylvania.

Phyllis favorite super hero is Batman.

Latest Posts

CDC Addresses Flu Vaccine Shortage


Did you get your flu shot this year? With 48 states reporting widespread influenza activity, flu season has come on fast and strong. As of the second week in January, according to data released by the Center for Disease Control (CDC), 29 children have died and 5,249 Americans have been hospitalized for flu-associated conditions. What’s been most worrisome, GEN’s Alex Philippidis writes, is that there have been spot shortages of the vaccine despite manufacturers producing 145 Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,